All Regulation articles – Page 17
-
NewsToxic tattoo inks face EU chemicals agency controls
Proposal to regulate 4000 substances used in permanent make-up and tattoo inks
-
NewsNew guidelines to standardise toxicity testing for nanomaterials
OECD hopes methods will ensure companies are singing from same song sheet on nanosafety
-
BusinessDrug formula change infuriates French thyroid patients
Poor communication of changes to Merck KGaA’s levothyroxine has led to complaints of side effects
-
NewsUproar over EPA’s plan to ban its grantees from science committees
EPA chief says members of its scientific advisory panels get ‘millions of dollars’ in grants from the agency, which poses conflicts of interest
-
BusinessEx-Chemours worker tried to steal trade secrets
Employee intended to sell confidential information about sodium cyanide to Chinese investors to set up competing plants
-
BusinessFederal court quashes Allergan eye drop patents
Ruling negates company’s deal with Mohawk tribe to avoid patent board review
-
BusinessBASF to buy Bayer seeds and herbicides
€5.9bn sale will help satisfy competition regulators’ worries over Bayer–Monsanto merger
-
BusinessCall for overhaul of EU rules on GMO clinical trial
Rules designed around genetically modified plants crops are holding back new cell and gene-based medicines
-
BusinessResidents sue Arkema over contamination
French chemical giant accused of releasing toxic chemicals from US plant in the wake of hurricane Harvey
-
NewsBan on the sale of acids to under-18s planned in UK
Home secretary announces measures to combat acid attacks
-
BusinessUS government urged to exercise drug patent rights
Campaign group says withdrawing Biogen’s license to government patents, or re-licensing them to other companies, could lower MS drug prices
-
BusinessUS state passes law blocking generic drug price-gouging
Despite industry opposition, Maryland will be able to fine companies for ‘excessive and unjustified’ price increases
-
BusinessAmgen partners to launch biosimilars in China
US biopharma and Chinese generics firm will co-develop medicines from Amgen’s pipeline focused on inflammation and oncology
-
BusinessUS probes opioid manufacturers
Attorneys general from 41 states will investigate companies over alleged fraudulent marketing and distribution of painkillers
-
NewsUS rules for ‘dual-use’ research found lacking
Regulations may overlook studies of concern and needlessly hamper other work
-
BusinessIndustry intervenes in chemical regulation lawsuits
Trade groups back up US EPA against environmental campaigners’ complaints of relaxation in new rules
-
BusinessFDA warns Pfizer subsidiary over Epipen malfunctions
Manufacturer did not fully investigate reports of patients dying after auto-injector failures
-
BusinessAsia’s age of regulation
Safety legislation and data sharing in Asia is making progress but highlights a global challenge
-
BusinessEU investigates Bayer’s Monsanto takeover plan
Commission raises concerns over reduced competition across pesticide and seed markets
-
BusinessHurricane hammers US chemical industry
Petrochemical sites along Houston’s seaboard are offline, and flooding has caused explosions at an Arkema facility